diltiazem has been researched along with betaxolol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abe, I; Fujishima, M; Ohya, Y; Setoguchi, M | 1 |
| Baik, SH; Cho, SK; Kim, EJ; Kim, SH; Kim, SS; Koh, KK; Kwon, KS; Lee, KH; Park, HB; Park, SJ | 1 |
| Friedman, R; Glasser, SP; Smith, LK; Talibi, T; Weir, EK | 1 |
| Baik, SH; Cho, SK; In, HH; Koh, KK; Kwon, KS; Moon, TH; Park, GS; Park, HB; Park, YS; Song, JH | 1 |
| Melena, J; Osborne, NN; Wood, JP | 1 |
1 review(s) available for diltiazem and betaxolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for diltiazem and betaxolol
| Article | Year |
|---|---|
Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Betaxolol; Chronic Disease; Digoxin; Diltiazem; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Ventricular Function | 1995 |
Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Betaxolol; Chronic Disease; Diltiazem; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Physical Exertion; Statistics as Topic; Syncope; Time Factors | 1994 |
Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Betaxolol; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Cross-Over Studies; Digoxin; Diltiazem; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Ventricular Dysfunction, Left | 1995 |
9 other study(ies) available for diltiazem and betaxolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[The hazards of combining beta receptor blockaders and certain calcium antagonists].
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Calcium Channel Blockers; Diltiazem; Drug Synergism; Drug Therapy, Combination; Female; Humans; Risk Factors | 1991 |
Inhibitory action of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein.
Topics: Animals; Betaxolol; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Electric Conductivity; Female; Guinea Pigs; In Vitro Techniques; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Portal Vein | 1995 |
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium | 1999 |